Michael Dowell Discusses State Regulatory Scrutiny of Pharmacy Benefit Managers
In The News | 1 min read
Sep 13, 2022
Hinshaw partner Michael Dowell recently authored a byline published by U.S. Pharmacist titled "State PBM Regulations Protecting Community Pharmacies." In the article, Dowell discusses state regulatory scrutiny of pharmacy benefit managers (PBMs), a legal challenge to that scrutiny on federal preemption grounds, and the general outlook for state regulation in the future.
Dowell outlines key provisions in various state PBM regulations, including the Oklahoma Patient’s Right to Pharmacy Choice Act. He anticipates that the regulatory landscape of PBMs will continue to change and notes that federal regulation of PBMs may occur in the near future. He advises that PBMs and multistate pharmacies operating in all states
should take notice of the recent legal developments and ensure that their operations and contracts are structured to comply with state PBM regulatory requirements. Community pharmacies should monitor changes in their state laws regulating PBMs and adopt their operational practices in a manner to optimize their statutory/regulatory rights.
"State PBM Regulations Protecting Community Pharmacies" was published by U.S. Pharmacist on August 16, 2022.
Related People
Related Capabilities
Related Locations
Featured Insights

Event
Apr 23, 2026
Driving Ahead: Insights from Industry Leaders Auto Finance Seminar

Healthcare Alert
Mar 26, 2026
Are You Beyond the Red Line? Mastering Your FQHC’s Scope of Project to Avoid Noncompliance

Webinar
Mar 24, 2026
David Alfini on How Regulatory Citations Become Senior Living Risk

Consumer Crossroads: Where Financial Services and Litigation Intersect
Mar 18, 2026
How Should Entities Prepare for California’s New DFAL Licensing Requirement?

Webinar
Mar 17, 2026
Legal Insights on Medical Aid in Dying from Katie Anderson and Adam Guetzow

Consumer Crossroads: Where Financial Services and Litigation Intersect
Mar 13, 2026
DOJ Settlement with Car Retailer Highlights SCRA Repossession Risks

Privacy, Cyber & AI Decoded Alert
Mar 11, 2026
Compliance Considerations for GDPR Consent in Biotech Clinical Research





![[VIDEO] Lucy Wang Featured in Business Interview TV Series](/a/web/28aUdvEJH2Txwy8MGsu35J/bo3TFX/featured-in-the-business-insurance-business-interview-series-insights.jpg)
